-
Je něco špatně v tomto záznamu ?
Synthesis and Characterization of a Bioartificial Polymeric System with Potential Antibacterial Activity: Chitosan-Polyvinyl Alcohol-Ampicillin
A. Bernal-Ballen, J. Lopez-Garcia, MA. Merchan-Merchan, M. Lehocky,
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 1997
Free Medical Journals
od 1997
PubMed Central
od 2001
Europe PubMed Central
od 2001
ProQuest Central
od 1997-01-01
Open Access Digital Library
od 1997-01-01
Medline Complete (EBSCOhost)
od 2009-03-01
Health & Medicine (ProQuest)
od 1997-01-01
- MeSH
- ampicilin * chemie farmakologie MeSH
- antibakteriální látky * chemická syntéza chemie farmakologie MeSH
- chitosan * chemie farmakologie MeSH
- Escherichia coli růst a vývoj MeSH
- polyvinylalkohol * chemie farmakologie MeSH
- Staphylococcus aureus růst a vývoj MeSH
- Publikační typ
- časopisecké články MeSH
Bio-artificial polymeric systems are a new class of polymeric constituents based on blends of synthetic and natural polymers, designed with the purpose of producing new materials that exhibit enhanced properties with respect to the individual components. In this frame, a combination of polyvinyl alcohol (PVA) and chitosan, blended with a widely used antibiotic, sodium ampicillin, has been developed showing a moderate behavior in terms of antibacterial properties. Thus, aqueous solutions of PVA at 1 wt.% were mixed with acid solutions of chitosan at 1 wt.%, followed by adding ampicillin ranging from 0.3 to 1.0 wt.% related to the total amount of the polymers. The prepared bio-artificial polymeric system was characterized by FTIR, SEM, DSC, contact angle measurements, antibacterial activity against Staphylococcus aureus and Escherichia coli and antibiotic release studies. The statistical significance of the antibacterial activity was determined using a multifactorial analysis of variance with ρ < 0.05 (ANOVA). The characterization techniques did not show alterations in the ampicillin structure and the interactions with polymers were limited to intermolecular forces. Therefore, the antibiotic was efficiently released from the matrix and its antibacterial activity was preserved. The system disclosed moderate antibacterial activity against bacterial strains without adding a high antibiotic concentration. The findings of this study suggest that the system may be effective against healthcare-associated infections, a promising view in the design of novel antimicrobial biomaterials potentially suitable for tissue engineering applications.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19012100
- 003
- CZ-PrNML
- 005
- 20190405101240.0
- 007
- ta
- 008
- 190405s2018 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/molecules23123109 $2 doi
- 035 __
- $a (PubMed)30486491
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Bernal-Ballen, Andres $u Grupo de Investigación en Ingeniería Biomédica, Vicerrectoría de Investigaciones, Universidad Manuela Beltrán, Avenida Circunvalar No. 60-00, Bogotá 1101, Colombia. andres_bernal9@hotmail.com.
- 245 10
- $a Synthesis and Characterization of a Bioartificial Polymeric System with Potential Antibacterial Activity: Chitosan-Polyvinyl Alcohol-Ampicillin / $c A. Bernal-Ballen, J. Lopez-Garcia, MA. Merchan-Merchan, M. Lehocky,
- 520 9_
- $a Bio-artificial polymeric systems are a new class of polymeric constituents based on blends of synthetic and natural polymers, designed with the purpose of producing new materials that exhibit enhanced properties with respect to the individual components. In this frame, a combination of polyvinyl alcohol (PVA) and chitosan, blended with a widely used antibiotic, sodium ampicillin, has been developed showing a moderate behavior in terms of antibacterial properties. Thus, aqueous solutions of PVA at 1 wt.% were mixed with acid solutions of chitosan at 1 wt.%, followed by adding ampicillin ranging from 0.3 to 1.0 wt.% related to the total amount of the polymers. The prepared bio-artificial polymeric system was characterized by FTIR, SEM, DSC, contact angle measurements, antibacterial activity against Staphylococcus aureus and Escherichia coli and antibiotic release studies. The statistical significance of the antibacterial activity was determined using a multifactorial analysis of variance with ρ < 0.05 (ANOVA). The characterization techniques did not show alterations in the ampicillin structure and the interactions with polymers were limited to intermolecular forces. Therefore, the antibiotic was efficiently released from the matrix and its antibacterial activity was preserved. The system disclosed moderate antibacterial activity against bacterial strains without adding a high antibiotic concentration. The findings of this study suggest that the system may be effective against healthcare-associated infections, a promising view in the design of novel antimicrobial biomaterials potentially suitable for tissue engineering applications.
- 650 12
- $a ampicilin $x chemie $x farmakologie $7 D000667
- 650 12
- $a antibakteriální látky $x chemická syntéza $x chemie $x farmakologie $7 D000900
- 650 12
- $a chitosan $x chemie $x farmakologie $7 D048271
- 650 _2
- $a Escherichia coli $x růst a vývoj $7 D004926
- 650 12
- $a polyvinylalkohol $x chemie $x farmakologie $7 D011142
- 650 _2
- $a Staphylococcus aureus $x růst a vývoj $7 D013211
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Lopez-Garcia, Jorge $u Centre of Polymer Systems, University Institute, Tomas Bata University in Zlín, Trida Tomase Bati 5678, 76001 Zlín, Czech Republic. lopez@utb.cz.
- 700 1_
- $a Merchan-Merchan, Martha-Andrea $u Maestría en Educación, Universidad Antonio Nariño, Conciencia, Calle 22 sur No. 12D-81, Bogotá 1101, Colombia. mmerchan30@uan.edu.co.
- 700 1_
- $a Lehocky, Marian $u Centre of Polymer Systems, University Institute, Tomas Bata University in Zlín, Trida Tomase Bati 5678, 76001 Zlín, Czech Republic. lehocky@utb.cz.
- 773 0_
- $w MED00180394 $t Molecules (Basel, Switzerland) $x 1420-3049 $g Roč. 23, č. 12 (2018)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30486491 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190405 $b ABA008
- 991 __
- $a 20190405101249 $b ABA008
- 999 __
- $a ok $b bmc $g 1391410 $s 1050405
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 23 $c 12 $e 20181128 $i 1420-3049 $m Molecules $n Molecules $x MED00180394
- LZP __
- $a Pubmed-20190405